Low-dose aspirin may reduce risk for COVID-19, study suggests
By (0)
A study in Israel suggests low-dose aspirin may reduce the risk for COVID-19, and shorten the illness for those who already take the drug and are sickened by the coronavirus. Photo by LizM/Pixabay
It s already being taken by millions to help ward off heart issues, and now preliminary research hints that daily low-dose aspirin might also cut your odds of contracting COVID-19.
As the Israeli research team noted, aspirin is an anti-inflammatory and previous studies have shown that it may help the immune system combat some viral infections.
Advertisement